ST-Segment–Elevation Myocardial Infarction During COVID-19 Pandemic
- 1 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
- Vol. 13 (8), e009413
- https://doi.org/10.1161/circinterventions.120.009413
Abstract
Background: Coronavirus disease 2019 (COVID-19) pandemic has led to a fast and radical transformation in social, economic, and healthcare networks. COVID-19 outbreak may thus have profound indirect consequences on clinical presentation and management of patients with ST-segment–elevation myocardial infarction (STEMI). Aim of this study was to assess clinical features of patients with STEMI during COVID-19 pandemic. Methods: This single-center, prospective study from a regional public service healthcare hub in Milan included all consecutive patients with STEMI admitted to our institute from February 21 to April 1, 2020 (during COVID-19 pandemic). These patients were compared with a historical cohort of patients admitted for STEMI during the analogous time period (February 21 to April 1) in 2018 and 2019, in terms of time from symptoms onset to hospital admission, clinical characteristics, and in-hospital outcomes. Results: A total of 26 patients were admitted for STEMI during the study period, and 7 (26.9%) of these patients tested positive for severe acute respiratory syndrome coronavirus 2. On admission, medical therapy, including angiotensin-converting enzyme inhibitors and angiotensin receptor blockers use, was similar between cohorts. Median (interquartile range) time from symptoms onset to hospital admission was significantly longer in 2020 as compared to the historical cohort (15.0 [2.0–48.0] versus 2.0 [1.0–3.0] hours; PPP=0.06). In-hospital death, thromboembolism, mechanical ventilation, or hemodynamic decompensation needing inotropic or mechanical support were similar between years. Conclusions: These preliminary results from a cardiovascular regional public service healthcare hub demonstrate a significantly longer time from symptoms onset to hospital admission among patients with STEMI during COVID-19 pandemic compared with the same time period in the previous 2 years. Download figure Download PowerPointKeywords
This publication has 25 references indexed in Scilit:
- Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failureThe Lancet, 2020
- ST-segment elevation myocardial infarctionNature Reviews Disease Primers, 2019
- Fourth universal definition of myocardial infarction (2018)Polish Heart Journal, 2018
- Reperfusion Treatment in Late Presentation Acute Myocardial Infarction Timing Is Not EverythingCirculation: Cardiovascular Interventions, 2018
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationPolish Heart Journal, 2018
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2017
- Effects of Response to 2014–2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West AfricaEmerging Infectious Diseases, 2016
- Predictors of Avoiding Medical Care and Reasons for Avoidance BehaviorMedical Care, 2014
- Impact of the Fall 2009 Influenza A(H1N1)pdm09 Pandemic on US HospitalsMedical Care, 2013